Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heald

Showing results (1211-1220 of 1,233) with videos related to

Pageof 124
Sort By:
Nature|October 12, 2018
The dispersion-brightness relation for fast radio bursts from a wide-field surveyR M Shannon, J-P Macquart, K W Bannister, et al.
Journal of Medicinal Chemistry|December 1, 2022
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3KαEmily J Hanan, Marie-Gabrielle Braun, Robert A Heald, et al.
American Journal of Human Genetics|July 17, 2020
Bi-allelic Mutations in M1AP Are a Frequent Cause of Meiotic Arrest and Severely Impaired Spermatogenesis Leading to Male InfertilityMargot J Wyrwoll, Şehime G Temel, Liina Nagirnaja, et al.
Journal of Medicinal Chemistry|October 6, 2022
Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase ThetaMartin L Stockley, Amanda Ferdinand, Giovanni Benedetti, et al.
Journal of Medicinal Chemistry|December 4, 2024
Discovery of ART0380, a Potent and Selective ATR Kinase Inhibitor Undergoing Phase 2 Clinical Studies for the Treatment of Advanced or Metastatic Solid CancersChristopher L Carroll, Michael G Johnson, Yanbing Ding, et al.
Bioorganic & Medicinal Chemistry Letters|July 3, 2007
Indanylacetic acids as PPAR-delta activator insulin sensitizersPhilip Wickens, Chengzhi Zhang, Xin Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of CancerElise A Olsen, Sean Whittaker, Youn H Kim, et al.
Atmospheric Chemistry and Physics|March 10, 2021
Constraining remote oxidation capacity with ATom observationsKatherine R Travis, Colette L Heald, Hannah M Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2026
The pharmacological profile of ART6043, a first-in-class clinical DNA polymerase theta polymerase domain inhibitor potentiating PARP inhibitor efficacyHelen M R Robinson, Vera Grinkevich, Jayesh B Majithiya, et al.
Nature|January 12, 2018
An extreme magneto-ionic environment associated with the fast radio burst source FRB 121102D Michilli, A Seymour, J W T Hessels, et al.
Pageof 124

Showing results (1211-1220 of 1,233) with videos related to

Sort By:
Pageof 124
Nature|October 12, 2018
The dispersion-brightness relation for fast radio bursts from a wide-field surveyR M Shannon, J-P Macquart, K W Bannister, et al.
Journal of Medicinal Chemistry|December 1, 2022
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3KαEmily J Hanan, Marie-Gabrielle Braun, Robert A Heald, et al.
American Journal of Human Genetics|July 17, 2020
Bi-allelic Mutations in M1AP Are a Frequent Cause of Meiotic Arrest and Severely Impaired Spermatogenesis Leading to Male InfertilityMargot J Wyrwoll, Şehime G Temel, Liina Nagirnaja, et al.
Journal of Medicinal Chemistry|October 6, 2022
Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase ThetaMartin L Stockley, Amanda Ferdinand, Giovanni Benedetti, et al.
Journal of Medicinal Chemistry|December 4, 2024
Discovery of ART0380, a Potent and Selective ATR Kinase Inhibitor Undergoing Phase 2 Clinical Studies for the Treatment of Advanced or Metastatic Solid CancersChristopher L Carroll, Michael G Johnson, Yanbing Ding, et al.
Bioorganic & Medicinal Chemistry Letters|July 3, 2007
Indanylacetic acids as PPAR-delta activator insulin sensitizersPhilip Wickens, Chengzhi Zhang, Xin Ma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of CancerElise A Olsen, Sean Whittaker, Youn H Kim, et al.
Atmospheric Chemistry and Physics|March 10, 2021
Constraining remote oxidation capacity with ATom observationsKatherine R Travis, Colette L Heald, Hannah M Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2026
The pharmacological profile of ART6043, a first-in-class clinical DNA polymerase theta polymerase domain inhibitor potentiating PARP inhibitor efficacyHelen M R Robinson, Vera Grinkevich, Jayesh B Majithiya, et al.
Nature|January 12, 2018
An extreme magneto-ionic environment associated with the fast radio burst source FRB 121102D Michilli, A Seymour, J W T Hessels, et al.
Pageof 124